The Effect of Orally Dosed Levagen+™ (palmitoylethanolamide) on Exercise Recovery in Healthy Males-A Double-Blind, Randomized, Placebo-Controlled Study

Nutrients. 2020 Feb 25;12(3):596. doi: 10.3390/nu12030596.

Abstract

The aim of this study was to evaluate the effect of palmitoylethanolamide (PEA), a cannabimimetic compound and lipid messenger, on recovery from muscle damaging exercise. Twenty-eight healthy young male participants attended the laboratory four times on subsequent days. In the first visit, baseline characteristics were recorded before participants were randomized to consume either liquid PEA (167.5 mg Levagen+ with 832.5 mg maltodextrin) or a matched placebo (1 g maltodextrin) drink. Leg press exercise consisted of four sets at 80% of one repetition maximum followed by a performance set. Muscle soreness, thigh circumference, blood lactate concentration, biomarkers of muscle damage and inflammation, and transcription factor pathways were measured pre- and immediately post-exercise and again at 1, 2, 3, 24, 48, and 72 h post-exercise. The leg press exercise increased (p < 0.05) blood lactate concentration and induced muscle damage as evidenced by increased muscle soreness, thigh circumference, biomarkers of muscle damage, and concentrations of tumor necrosis factor-α. PEA reduced (p < 0.05) myoglobin and blood lactate concentrations and increased protein kinase B phosphorylation following exercise. Taken together, these results indicate PEA supplementation may aid in muscle recovery from repeat bouts of exercise performed within a short duration by reducing myoglobin and lactate concentration.

Keywords: functional foods; leg press exercise; muscle damage; palmitoylethanolamide; recovery.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Amides / administration & dosage*
  • Biomarkers / blood
  • Biomarkers / metabolism
  • Cannabinoid Receptor Agonists / administration & dosage*
  • Double-Blind Method
  • Ethanolamines / administration & dosage*
  • Exercise / physiology*
  • Healthy Volunteers
  • Humans
  • Lactic Acid / blood
  • Lactic Acid / metabolism
  • Male
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / physiopathology
  • Myalgia / blood
  • Myalgia / drug therapy*
  • Myalgia / etiology
  • Myoglobin / blood
  • Myoglobin / metabolism
  • Palmitic Acids / administration & dosage*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / blood
  • Tumor Necrosis Factor-alpha / metabolism
  • Young Adult

Substances

  • Amides
  • Biomarkers
  • Cannabinoid Receptor Agonists
  • Ethanolamines
  • Myoglobin
  • Palmitic Acids
  • TNF protein, human
  • Tumor Necrosis Factor-alpha
  • Lactic Acid
  • palmidrol

Grants and funding